Talk to Sam

+1 917 267 7886

Search inside this page

All regions

Free Market Research Guides to Download

Drug Discovery and Development Market Statistics, May 2013

You might be interested in: clinical trial, drug discovery, drug development, more »

» Read Business News

1-30 of about 6 700 news
Clinical Trial Innovation Trends in The United States: US Dollars 640000  Funding Available for Pilot Clinical Trial Award for Tuberous Sclerosis

Clinical Trial Innovation Trends In The United States: Us Dollars 640000 Funding Available For Pilot Clinical Trial Award For Tuberous Sclerosis

  • Company news
  • 10 hours ago
  • by Targeted News Service

by VARALAKSHMI PULUGURTHA Targeted News Service WASHINGTON , 2013-05-26 -- The U.S. Army Medical Research Acquisitions Activity has announced that it expects to award a maximum of 2 discretionary cooperative agreement grants to promote innovative research focused on decreasing the clinical impact of tuberous sclerosis complex. The estimated total program funding available was cited as ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Clinical Trial Trends in The United States: US Dollars 2.9M  Funding Available for DoD Neurofibromatosis Clinical Trial Award

Clinical Trial Trends In The United States: Us Dollars 2.9m Funding Available For Dod Neurofibromatosis Clinical Trial Award

  • Industry news
  • 10 hours ago
  • by Targeted News Service

by MARY GRACE DEJUCOS Targeted News Service WASHINGTON , 2013-05-26 -- The U.S. Army Medical Research Acquisition Activity has announced that it expects to award a maximum of 2 cooperative agreement grants to decrease the clinical impact of neurofibromatosis. The estimated total program funding available was cited as US Dollars 2.9 million . This funding opportunity is open to any entity, suc...

  • Industries : Drug Discovery and Development
  • Countries : United States
Clinical Research Innovation: Huge increase in volunteers for drug trials

Clinical Research Innovation: Huge Increase In Volunteers For Drug Trials

  • Industry news
  • 1 day ago
  • by Independent Print Limited

The number of volunteers taking part in clinical drugs trials in England has trebled in 5 years despite a shocking case in 2006 that saw 6 men treated for multiple organ failures, new figures show. Figures from the National Institute of Health Research (NIHR) show almost 638,000 patients volunteered last year - c...

  • Industries : Drug Discovery and Development
Clinical Trial Industry Overview in China: China Pharma Holdings Updates on 1Q 2013 Financial Results

Clinical Trial Industry Overview In China: China Pharma Holdings Updates On 1q 2013 Financial Results

  • Industry news
  • 1 day ago
  • by ProQuest Information & Learning

China Pharma Holdings, incorporated announced financial results for the 3 months ended 2013-03-31 . In a release on May 15 , the Industry player said that highlights include: -Revenue decreased 49 % to US Dollars 8.2 milliQ1rst quarter of 2013 from US Dollars Q1 in the first quarter of 2012. -Gross loss was Q1.6 million in the first quarter of 2013, a decrease of US Dollars 6.9 million compared...

  • Industries : Drug Discovery and Development
  • Countries : China
Clinical Trial Technology Trends in Russian Federation: AtheroNova Mentioned by Analyst in Life Sciences Report

Clinical Trial Technology Trends In Russian Federation: Atheronova Mentioned By Analyst In Life Sciences Report

  • Industry news
  • 2 days ago
  • by Baystreet.ca

Category: Baystreet Newswire Industry player: Emerging Growth Corp. ID: 404428 Date: Friday, 2013-05-24 Ticker: PK:AHRO Mont Blanc Capital Equity Research issued a research update on May 14, 2013 for AtheroNova incorporated (OTC Markets: AHRO). In the report, the analyst maintained its Buy rating , US Dollars 2.00 per share price target, while projecting that Phase I clinical trials wou...

  • Industries : Drug Discovery and Development
  • Countries : Russian Federation
Drug Discovery and Development Innovation Trends in The United States: Arena Pharmaceuticals to Present at 2 Upcoming Investor Conferences

Drug Discovery And Development Innovation Trends In The United States: Arena Pharmaceuticals To Present At 2 Upcoming Investor Conferences

  • Company news
  • 2 days ago
  • by PR Newswire

SAN DIEGO , 2013-05-24 /PRNewswire/ --  Arena Pharmaceuticals, incorporated (NASDAQ: ARNA) announced today that the Industry player is scheduled to present a corporate overview at the following investor conferences: Deutsche Bank Securities 38 th Annual Health Care Conference Presentation: May 30, 2013 , at 12:00 p.m. Eastern Time ( 9:00 a.m. Pacific Time ) at The Westin Bos...

  • Industries : Drug Discovery and Development
  • Countries : United States
Apricus Biosciences incorporated expects us dollar17.1m in public offering

Apricus Biosciences Incorporated Expects Us Dollar17.1m In Public Offering

  • Industry news
  • 2 days ago
  • by M2 Communications

Pharmaceutical Industry player Apricus Biosciences incorporated (NasdaqCM:APRI) said on Thursday that it has priced an us dollar17.1m underwritten public offering of common stock , warrants. The Industry player has priced the public offering of 6m common shares at us dollar2.85 per share , warrants to purchase up to an aggregate of 3m common shares for gross offering proceeds of us dollar17.1m . The common shares , warran...

  • Industries : Drug Discovery and Development
Clinical Trial Technology Trends in Spain, France and Germany: Safety results from Auris Medical AG's clinical development of AM-101 presented at International Conference.

Clinical Trial Technology Trends In Spain, France And Germany: Safety Results From Auris Medical Ag's Clinical Development Of Am-101 Presented At International Conference.

  • Industry news
  • 2 days ago
  • by Elsevier CBNB

Key safety outcomes from Auris Medical's clinical development of AM-101, a novel intratympanic (it) treatment for acute inner ear tinnitus, were presented at the 7th International TRI Tinnitus Conference in Valencia, Spain . The accumulated data demonstrate that the treatment , the administration procedure are well tolerated , safe even when repeated several times. The outcomes were prese...

  • Industries : Drug Discovery and Development
  • Countries : Spain, France, Germany
Clinical Study Technology Trends in The United States: World Intellectual Property Organization PUBLISHES PATENT OF TRANSPARENCY LIFE SCIENCE FOR

Clinical Study Technology Trends In The United States: World Intellectual Property Organization Publishes Patent Of Transparency Life Science For "systems And Methods For Clinical Protocol Development" (american Inventors)

  • Industry news
  • 2 days ago
  • by HT Media

GENEVA , 2013-05-24 -- Publication No. WO/2013/074922 was published on May 23 . Title of the invention: "SYSTEMS , METHODS FOR CLINICAL PROTOCOL DEVELOPMENT." Applicants: TRANSPARENCY LIFE SCIENCE LLC (US). Inventors: Tomasz Sablinski (US), Marc Foster (US), Martin Streeter (US), Gareth Hicks (US) , Lawrence Steinman (US). as reported by the abstract* posted by the World In...

  • Industries : Drug Discovery and Development
  • Countries : United States
Clinical Trial Innovation Trends in The United States: Merck Provides Update on Phase III Clinical Program for Preladenant, the Industry player?s Investigational Parkinson?s Disease Medicine

Clinical Trial Innovation Trends In The United States: Merck Provides Update On Phase Iii Clinical Program For Preladenant, The Industry Player?s Investigational Parkinson?s Disease Medicine

  • Company news
  • 2 days ago
  • by Business Wire

WHITEHOUSE STATION, N.J. --(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States , Canada , today provided an update on the clinical program for preladenant, Merck?s investigational adenosine A2 A receptor antagonist for the treatment of Parkinson?s disease (PD). An initial review of data from 3 separate Phase III trials did no...

  • Industries : Drug Discovery and Development
  • Countries : United States
Clinical Trial Innovation in Canada: Adhering to Good Clinical Practice, New Webinar Hosted by Xtalks

Clinical Trial Innovation In Canada: Adhering To Good Clinical Practice, New Webinar Hosted By Xtalks

  • Industry news
  • 3 days ago
  • by PR Web

Toronto, Canada (PRWEB) 2013-05-23 During the conduct of research involving human subjects, it is critical to adhere to principles of good clinical practice (GCP) , human subject protection (HSP). Esteemed speaker Dr. Jeremy Lim , Fellow, Clinical Development at Novartis Pharmaceuticals , will help the audience:    ?      Understand the International Conference on Harmoniza...

  • Industries : Drug Discovery and Development
  • Countries : Canada
Clinical Trial Innovation Trends: Tufts CSDD Study Finds Adoption of Adaptive Clinical Trial Designs Is Increasing

Clinical Trial Innovation Trends: Tufts Csdd Study Finds Adoption Of Adaptive Clinical Trial Designs Is Increasing

  • Company news
  • 3 days ago
  • by Business Wire

Report Shows Growing Acceptance by Pharmaceutical Companies , Regulatory Agencies RESTON, Va. --(BUSINESS WIRE)-- Aptiv Solutions, a biopharmaceutical , medical device development services Industry player , pioneer in adaptive clinical trial design, simulation , execution, declares publication of a Tufts Center for the Study of Drug De...

  • Industries : Drug Discovery and Development
Drug Discovery and Development Production Statistics: Spectrum Pharmaceuticals to Present Corporate Update at the Deutsche Bank 38th Annual Health Care Conference in Boston on May 30th

Drug Discovery And Development Production Statistics: Spectrum Pharmaceuticals To Present Corporate Update At The Deutsche Bank 38th Annual Health Care Conference In Boston On May 30th

  • Company news
  • 3 days ago
  • by Business Wire

HENDERSON, Nev. --(BUSINESS WIRE)-- Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology Industry player with fully integrated commercial , drug development operations with a primary focus in hematology , oncology, today announced that an overview of the Industry player's business strategy , commercial , development-stage programs will be given at the Deutsc...

  • Industries : Drug Discovery and Development
Clinical Trial Innovation in South Korea: Pusan National University declares Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment

Clinical Trial Innovation In South Korea: Pusan National University Declares Science Translational Medicine Publication Highlighting Landmark Demonstration Of Functional Anti-cancer Antibody Induction In Patients Following Jx-594 Treatment

  • Industry news
  • 3 days ago
  • by PR Newswire

BUSAN, South Korea , 2013-05-23 /PRNewswire/ -- Pusan National University Yangsan Hospital , in collaboration with SillaJen, incorporated , a private biotherapeutics , contract research Industry player focused on research , development of targeted biological products for cancer, announced today a publication reporting the induction of functional anti-cancer antibodies in patients treated...

  • Industries : Drug Discovery and Development
  • Countries : South Korea
Clinical Trial and Drug Research Innovation Trends in The United States: Merck KGaA brings in outside help for clinical development.

Clinical Trial And Drug Research Innovation Trends In The United States: Merck Kgaa Brings In Outside Help For Clinical Development.

  • Company news
  • 3 days ago
  • by Elsevier CBNB

Merck KGaA is to use external contract researchers to increase the efficiency of its drugs research , development. US Industry player Quintiles will in future plan , undertake all clinical tri...

  • Industries : Drug Discovery and Development
  • Countries : United States
Drug Discovery and Development Market in The United States: Ignyta Acquires Actagene Oncology and Entry into Oncology Personalized Medicine

Drug Discovery And Development Market In The United States: Ignyta Acquires Actagene Oncology And Entry Into Oncology Personalized Medicine

  • Industry news
  • 3 days ago
  • by ProQuest Information & Learning

Ignyta, incorporated announced that it has acquired Actagene Oncology, incorporated , effective May 20 . Actagene was a San Diego based privately held biotechnology Industry player founded in February 2013 that was developing personalized medicines for high unmet need cancer indications, based on cancer genome mining , sequencing. In a release, the Industry player noted that the with the acquisition, Ignyta has ev...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Pharmaceutical R&d Technology Trends: Global Pharmaceutical R&D Pipeline

Pharmaceutical R&d Technology Trends: Global Pharmaceutical R&d Pipeline

  • Industry news
  • 3 days ago
  • by ProQuest Information & Learning

Global pharmaceutical novel drug approvals will moderate in 2013 due to the exceptional research success in 2012, as reported by a Fitch Ratings report. The U.S. Food , Drug Administration (FDA) approved 12 new molecular entities (NMEs) in the Q1 of 2013. Fitch expects cancer drugs to lead specialty drug authorizations again in 2013, but new diabetes treatments...

  • Industries : Drug Discovery and Development
  • Countries : World
Clinical Trial and Drug Development Key Players in The United States: Multiple Target ALS Drug Ready for Phase 2 Trial

Clinical Trial And Drug Development Key Players In The United States: Multiple Target Als Drug Ready For Phase 2 Trial

  • Industry news
  • 3 days ago
  • by ProQuest Information & Learning

Multiple targets, highly effective therapy for ALS sufferers may now be within reach. In a release, the Industry player said that Winston Ko , CEO of Genervon Biopharmaceuticals, will be presenting on Friday at the Neurotech Conference in San Francisco that its endogenous regulatory drug GM604 modulates over 80 ALS related gene targets interactively , dynamically through 12 pathways , up to ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Clinical Trial Innovation Trends in The United States: CytRx Presents Initial Findings from Pharmacokinetics Clinical Trial with Aldoxorubicin in Solid Tumors

Clinical Trial Innovation Trends In The United States: Cytrx Presents Initial Findings From Pharmacokinetics Clinical Trial With Aldoxorubicin In Solid Tumors

  • Company news
  • 3 days ago
  • by ProQuest Information & Learning

CytRx Corp. , a biopharmaceutical research , development Industry player specializing in oncology, has announced initial data from a Phase 1b clinical trial evaluating the pharmacokinetics , safety of aldoxorubicin, its novel conjugate of the widely used chemotherapeutic agent doxorubicin, in patients with metastatic solid tumors who have either relapsed or not responded to treatment with standard...

  • Industries : Drug Discovery and Development
  • Countries : United States
Drug Discovery and Development Market Position in India: Ranbaxy under India's drug regulator scanner

Drug Discovery And Development Market Position In India: Ranbaxy Under India's Drug Regulator Scanner

  • Company news
  • 3 days ago
  • by HT Media

New Delhi , 2013-05-23 -- India's pharmaceutical Market regulator will scrutinize all drug applications , dossiers filed by Ranbaxy Laboratories Ltd , as well as court documents presented in the US, to find out if there have been any breaches of the Drug , Cosmetics (D&C) Act, said Drug Controller General of India (DCGI) G.N Singh in an interview. The action comes after Ranbaxy on 1...

  • Industries : Drug Discovery and Development
  • Countries : India
Drug Discovery and Development Innovation Trends in The United States:

Drug Discovery And Development Innovation Trends In The United States: "method For Predicting Admet Properties Using Abbreviated Profile Of Drugs (a-pod)" In Patent Application Approval Process

  • Company news
  • 3 days ago
  • by NewsRx.com

By a News Reporter-Staff News Editor at Politics & Government Week -- A patent application by the inventors HIREMATH, CHAITANYA N . ( WESTFORD, MA ), filed on December 24, 2012 , was made available online on 2013-05-16 , as reported by news reporting originating from Washington, D.C. , by VerticalNews correspondents. Patent application serial number 726519 has not been assigned to a com...

  • Industries : Drug Discovery and Development
  • Countries : United States
Drug Discovery and Development Trends in China: Data on DNA Research Described by Researchers at Henan Normal University

Drug Discovery And Development Trends In China: Data On Dna Research Described By Researchers At Henan Normal University

  • Industry news
  • 3 days ago
  • by NewsRx.com

By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators discuss new findings in DNA Research . as reported by news originating from Xinxiang, People's Republic of China , by NewsRx correspondents, research stated, "The effects of substituent modifications for 3 dihydropyrimidinones derivatives on DNA binding properties were investigated using viscometry in combination wit...

  • Industries : Drug Discovery and Development
  • Countries : China
Clinical Trial Innovation in The United States: Findings in Clinical Trials and Studies Reported from W. Collinge and Company-Researchers

Clinical Trial Innovation In The United States: Findings In Clinical Trials And Studies Reported From W. Collinge And Company-researchers

  • Industry news
  • 3 days ago
  • by NewsRx.com

By a News Reporter-Staff News Editor at Cancer Weekly -- Current study results on Research have been published. as reported by news reporting from San Diego, California , by NewsRx journalists, research stated, "A randomized controlled trial was conducted to evaluate outcomes of a multimedia instructional program for family caregivers in simple touch-based techniques to provide comfort to ca...

  • Industries : Drug Discovery and Development
  • Countries : United States
Clinical Trial Innovation in Spain and The United States: Researchers from Central University Discuss Findings in Clinical Trials and Studies

Clinical Trial Innovation In Spain And The United States: Researchers From Central University Discuss Findings In Clinical Trials And Studies

  • Industry news
  • 3 days ago
  • by NewsRx.com

By a News Reporter-Staff News Editor at Cancer Weekly -- Researchers detail new data in Research. as reported by news reporting from Oviedo, Spain , by NewsRx journalists, research stated, "The overall number of cancer cases is increasing ,, therefore, strengthening cancer prevention has become a priority. The institutions responsible for its control establish guidelines for primary preven...

  • Industries : Drug Discovery and Development
  • Countries : Spain, United States
Analytical Chemistry Innovation Trends in The United States: New Findings from Vanderbilt University Update Understanding of Analytical Chemistry

Analytical Chemistry Innovation Trends In The United States: New Findings From Vanderbilt University Update Understanding Of Analytical Chemistry

  • Company news
  • 3 days ago
  • by NewsRx.com

By a News Reporter-Staff News Editor at Proteomics Weekly -- Researchers detail new data in Analytical Chemistry. as reported by news reporting originating from Nashville, Tennessee , by NewsRx correspondents, research stated, "Peptide sequence matching algorithms used for peptide identification by tandem mass spectrometry (MS/MS) enumerate theoretical peptides from the database, predict the...

  • Industries : Drug Discovery and Development
  • Countries : United States
Clinical Trial Innovation Trends in The United States: Data on Clinical Trials and Studies Reported by Researchers at F. Hoffmann-La Roche

Clinical Trial Innovation Trends In The United States: Data On Clinical Trials And Studies Reported By Researchers At F. Hoffmann-la Roche

  • Company news
  • 3 days ago
  • by NewsRx.com

By a News Reporter-Staff News Editor at TB & Outbreaks Week -- Investigators publish new report on Research. as reported by news reporting originating from Nutley, New Jersey , by NewsRx correspondents, research stated, "We conducted in vitro experiments to determine the potency of balapiravir against dengue viruses , then an exploratory, dose-escalating, randomized placebo-controlled trial ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Drug Discovery and Development Trends in Germany: Researchers at Institute of Structural Biology Target Laboratory Animals

Drug Discovery And Development Trends In Germany: Researchers At Institute Of Structural Biology Target Laboratory Animals

  • Industry news
  • 3 days ago
  • by NewsRx.com

By a News Reporter-Staff News Editor at Life Science Weekly -- Data detailed on Laboratory Animals have been presented. as reported by news reporting originating in Munich, Germany , by NewsRx journalists, research stated, "The prioritisation of chemical compounds is important for the identification of those chemicals that represent the highest threat to the environment. As part of the CADAS...

  • Industries : Drug Discovery and Development
  • Countries : Germany
Drug Target Innovation Trends in Pakistan: New Eukaryotic Research Study Findings Recently Were Reported by Researchers at Aga Khan University

Drug Target Innovation Trends In Pakistan: New Eukaryotic Research Study Findings Recently Were Reported By Researchers At Aga Khan University

  • Company news
  • 3 days ago
  • by NewsRx.com

By a News Reporter-Staff News Editor at Life Science Weekly -- Fresh data on Eukaryotic Research are presented in a new report. as reported by news reporting out of Karachi, Pakistan , by NewsRx editors, research stated, "The opportunist free-living protists such as Acanthamoeba spp. , Balamuthia mandrillaris have become a serious threat to human life." Our news journalists obtained a ...

  • Industries : Drug Discovery and Development
  • Countries : Pakistan
Drug Discovery and Development Innovation in South Korea: Findings from Research Laboratory Yields New Findings on Medicinal Chemistry

Drug Discovery And Development Innovation In South Korea: Findings From Research Laboratory Yields New Findings On Medicinal Chemistry

  • Industry news
  • 3 days ago
  • by NewsRx.com

By a News Reporter-Staff News Editor at Life Science Weekly -- New research on Medicinal Chemistry is the subject of a report. as reported by news reporting originating in Yongin, South Korea , by NewsRx journalists, research stated, "The polo-box domain (PBD) of polo-like kinase 1 (Plk1) is essentially required for the function of Plk1 in cell proliferation. The availability of the phosphop...

  • Industries : Drug Discovery and Development
  • Countries : South Korea
Drug Development Trends in The United States: Researchers at Center for Drug Evaluation and Research Release New Data on Toxicology and Applied Pharmacology

Drug Development Trends In The United States: Researchers At Center For Drug Evaluation And Research Release New Data On Toxicology And Applied Pharmacology

  • Industry news
  • 3 days ago
  • by NewsRx.com

By a News Reporter-Staff News Editor at Biotech Week -- Researchers detail new data in Toxicology , Applied Pharmacology. as reported by news reporting out of Silver Spring, Maryland , by NewsRx editors, research stated, "Drug-induced phospholipidosis (DIPL) is a preclinical finding during pharmaceutical drug development that has implications on the course of drug development , regulatory ...

  • Industries : Drug Discovery and Development
  • Countries : United States

Reportlinker.com © Copyright 2013. All rights reserved.

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.